Algur H. Meadows Imaging Center Alzheimer Center Depression and Anxiety Disorders Program Mary Nell and Ralph B. Rogers Imaging Center Neurology Nuclear Medicine Center Otolaryngology Positron Emission Tomography (PET) Facility Psychiatry Psychiatry - Alzheimers Radiology
Dr. Devous is a Professor of Radiology, Radiological Sciences and Bioengineering, Director of the Neuroimaging Core for the Alzheimer?s Disease Center and of the Neuroimaging Core for a Traumatic Brain Injury Program Project and Associate Director of the Nuclear Medicine Center at the University of Texas Southwestern Medical Center, Dallas, Texas. He is also an Adjunct Professor of Brain and Behavioral Sciences at the University of Texas at Dallas and co-Directs the Center for Brain, Cognition and Behavior. He has authored more than 100 peer-reviewed articles, 200 abstracts, and 30 books or book chapters and serves as an editorial board member or consultant on more than a dozen journals. He is currently Principal or Co-Investigator on 7 active grants (3 NIH, 1 DOD, 1 private foundation [Dana] and 2 clinical trials) with $5.9M in total direct costs. Dr. Devous is past president of the Society of Nuclear Medicine, current President of the Education and Research Foundation, on the Board of Directors of the Academy of Radiology Research, and former chair of the Medical Imaging Drugs Advisory Committee for the Food and Drug Administration. He is a co-developer of the first triple-head SPECT scanner and led the clinical trials for the only two FDA-approved SPECT brain imaging agents. His research is organized into four areas: 1) investigating the biologic underpinnings of psychiatric and neurologic disorders through functional brain imaging techniques; 2) studies of normal brain function using functional brain imaging techniques; 3) three-dimensional models for the extraction and analysis of functional brain imaging data; and 4) physiologic investigations of the sequelae of CNS pathology in animal models. These investigations focus on the biologic bases of and treatments for psychiatric disorders (anxiety disorders, bipolar disorder, dementia, mood disorders, schizophrenia and substance abuse), neurologic disorders (arteriovenous malformation, cerebrovascular disease, epilepsy and head trauma) and speech and communication disorders (aphasia, deafness, spasmodic dysphonia and stuttering). He has received numerous awards, including: Presidential Distinguished Service Award - Society of Nuclear Medicine; Outstanding Clinical Investigation - Journal of Nuclear Medicine; Scientific Merit First Award - American Speech, Language and Hearing Association; Award of Merit - Hong Kong Society of Nuclear Medicine; and Finalist NARSAD Distinguished Investigator Award. Dr. Devous recently received a distinguished ?Clinical Hypotheses in Brain Function? Award from the Dana Foundation. He was also chosen as the 2004 Kuhl-Lassen Award recipient, the highest award of the Brain Imaging Council and the Society of Nuclear Medicine. The award honors scientists who have made significant contributions by the body of their work to the field of functional brain imaging.
